SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 2 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $625 | -100.0% | 27,022 | -68.0% | 0.01% | -81.2% |
| Q3 2022 | $2,413,000 | +264.0% | 84,573 | +214.2% | 0.03% | +300.0% |
| Q2 2022 | $663,000 | +151.1% | 26,921 | +640.8% | 0.01% | +166.7% |
| Q4 2020 | $264,000 | -23.9% | 3,634 | -56.0% | 0.00% | -66.7% |
| Q2 2020 | $347,000 | -58.5% | 8,267 | -73.3% | 0.01% | -80.4% |
| Q1 2020 | $837,000 | – | 30,996 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $272,679,000 | 26.48% |
| Boxer Capital, LLC | 2,075,905 | $117,164,000 | 6.02% |
| Orbimed Advisors | 6,028,307 | $340,238,000 | 5.52% |
| Perceptive Advisors | 4,527,993 | $255,560,000 | 5.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 460,025 | $25,964,000 | 3.67% |
| Affinity Asset Advisors, LLC | 247,000 | $13,941,000 | 2.23% |
| Artal Group S.A. | 850,000 | $47,974,000 | 2.01% |
| Affinity Asset Advisors, LLC | 160,000 | $9,030,000 | 1.44% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,841,799 | $103,951,000 | 1.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $7,055,000 | 1.00% |